Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Journal of Bone Metabolism ; : 135-142, 2016.
Article in English | WPRIM | ID: wpr-147421

ABSTRACT

BACKGROUND: In 1951, Ardran reported that metastatic bone lesions could be detectable on plain radiography with 30% to 50% of decalcification. Authors performed experimental study for minimum level of decalcification to detect the osteolytic bone metastasis of long bone with recent technique of radiographs. METHODS: One pair of fibula and humerus from two cadavers was cut into specimen 1 inch in length. Distal half of specimen was dipped into hydrochloride (HCl) with 15 min interval. All 16 specimens were checked by film-type radiography (FR), computed radiography (CR), digital radiography (DR). To exclude inter-observer's variance, 3 radiologists evaluated images. Calcium amount before and after decalcification was measured and expressed in percentage of decalcification. RESULTS: Osteolytic changes were detectable with 11% to 16% of decalcification for fibula and 3% to 8% for humerus on plain radiography with FR, CR, and DR. CONCLUSIONS: Our study showed that minimum of 3% and maximum of 16% of decalcification is necessary when osteolytic metastatic bone lesions of long bone could be detected on plain radiography.


Subject(s)
Cadaver , Calcium , Decalcification Technique , Fibula , Humerus , Neoplasm Metastasis , Osteolysis , Radiographic Image Enhancement , Radiography
2.
Journal of Bone Metabolism ; : 205-212, 2014.
Article in English | WPRIM | ID: wpr-86729

ABSTRACT

INTRODUCTION: Bone mineral density (BMD) is an important index in diagnosis of osteoporosis and other metabolic bone diseases, prediction of fractures, and monitoring treatment. This study was to find a more feasible technique for prediction of osteoporotic fracture between dual energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT) and to reveal the actual change of bone strength when BMD was changed. METHODS: Ten of these 20 specimens were used as the demineralized group and the other 10 as the control. Each specimen was immersed in HCl solution at for a period of at least 10 minutes, up to 100 minutes, at an interval of 10 minutes for different levels of demineralization. BMD was measured using DXA and QCT. Uniaxial compression tests were conducted to measure biomechanical parameters. Pearson correlation analysis was used respectively between BMD and biomechanical parameters and between DXA and QCT. RESULTS: Elastic modulus (r=0.87) and yield stress (r=0.84) showed a statistically significant correlation with DXA BMD. Through correlation analysis with QCT BMD and elastic modulus, correlation coefficient showed hemi-vertebra (r=0.80) and trabecular (r=0.68). In yield stress, there was a statistically significant correlation in hemi-vertebra (r=0.87) and trabecular bone (r=0.84). CONCLUSION: DXA is a current standard technique not only for diagnosis of osteoporosis but also for prediction of fracture risk compared to QCT. Actual decrease of bone strength was much greater than that of BMD by both DXA and QCT.


Subject(s)
Absorptiometry, Photon , Biomechanical Phenomena , Bone Density , Bone Diseases, Metabolic , Diagnosis , Elastic Modulus , Osteoporosis , Osteoporotic Fractures
3.
Journal of Korean Society of Osteoporosis ; : 28-36, 2011.
Article in English | WPRIM | ID: wpr-760762

ABSTRACT

OBJECTIVES: We performed research and analysis to determine the risk factors of osteoporosis for women after menopause by conducting a survey and measuring the bone density through a free program to diagnose osteoporosis. SUBJECTS AND METHODS: Kyungpook National University organized and then started the free osteoporosis diagnosis program on May 11 in 2005. One hundred forty six women whose age was between the early forties and late eighties took the survey. The risk factors for osteoporosis were analyzed according to the data which was obtained from the survey. The measurements of the bone mineral density (BMD) of right calcaneus area were recorded by the use of ultrasound equipment. RESULTS: Within the results, between the advancing age (P=0.000) of subjects, the lower BMI (P=0.002), the more children (P=0.004), the breast fed longer (P=0.047), the individuals who had a lower age when menopause began (P=0.037) and their BMD showed significant correlation. CONCLUSIONS: The results express that the osteoporosis risk-factors for Korean women, despite the advancing age and the lower BMI as absolute factors, that the more children, the longer breast feeding and the lower the age that menopause began, would result in a lower density of bone.


Subject(s)
Child , Female , Humans , Bone Density , Breast , Breast Feeding , Calcaneus , Menopause , Osteoporosis , Surveys and Questionnaires , Risk Factors
4.
Korean Journal of Bone Metabolism ; : 49-54, 2011.
Article in Korean | WPRIM | ID: wpr-212726

ABSTRACT

OBJECTIVE: Bisphosphonates are the most commonly prescribed medications for the treatment of osteoporosis. This study was designed to analyze the rate of acute phase reaction (APR) following Zoledronate 5 mg administration in patients with osteoporosis who were treated with prior oral bisphosphonate for at least 2 weeks and to compare naive IV 5 mg Zoledronate. METHODS: Between July 2009 and October 2010, 27 patients with osteoporosis who were treated with prior oral bisphosphonate for at least 2 weeks, and maximum 52 weeks (average 18.5 weeks) and were between 42-and 85-year-old at the time of study participation. We prospectively evaluated APR, including fever, flu-like symptoms, headache, arthralgia, and myalgia, after 5 mg zoledronate by questionnaire. Additionally we assessed a visual analogue scale (VAS) by 4-point categorical scale. RESULTS: In this study of 27 patients with osteoporosis, the frequency of APR, flu-like symptom and myalgia were 14.8% and 7.4% and fever, arthralgia, and headache were 3.7% respectively. In VAS, all reactions were mild. The rate of APR rate in this study was statistically decreased compared to previous reports with zoledronate 5 mg IV in bisphosphonate-naive patients. CONCLUSION: Prior oral bisphosphonate administration for at least 2 weeks could significantly reduce the APR of IV zoledronate 5 mg.


Subject(s)
Aged, 80 and over , Humans , Acute-Phase Reaction , Arthralgia , Diphosphonates , Fever , Headache , Imidazoles , Osteoporosis , Prospective Studies , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL